IRYCIS

miRNA 127 agents for use in the treatment of renal fibrosis

Biomarkers / Diagnostic
Kidney and Genitourinary system
a method of prophylactically or therapeutically treating Chronic kidney disease (CKD) or of reducing the risk of CKD disease progression in a patient comprising expressing miR-127 in the renal cells
3Clinical validation, 2Preclinical Validation, 1R+D
Spain